Winway Health Desk
Takeda swings and misses with Ninlaro in AL amyloidosis, calls off...
With its once-biggest seller Velcade bracing for generic competition, Takeda has big plans for its oral multiple myeloma drug Ninlaro. But now, the med has...
Report: Warrant issued for arrest of Samsung BioLogics exec in $3.9B...
An executive from the biologics arm of Korean conglomerate Samsung faces arrest as part of a probe into the company’s accounting practices.
The Korean wire...
Charity urges government not to compromise restaurant food labelling
A major diabetes organisation is urging the government not to "water down" plans to introduce food labelling in restaurants.In a bid to...
Greek Pimiento Burgers | Breaking Muscle
Take a summer food vacation to Greece by combining all of the signature flavors in a tasty, grilled burger! These burgers can easily be...
Was ASCO 2019 ‘quiet’? Pharma, biotech execs weigh in
It started well before last weekend.
For months, rumors flew that this year’s American Society of Clinical Oncology annual meeting would lack some of the...
What are the latest results from Medicare’s Oncology Care Model?
The Oncology Care Model (OCM) was launched in July 2016 to further delivery of higher quality, more coordinated cancer care at a lower cost...
Mallinckrodt hit with new kickback charges same day as $15.4M settlement...
Chafing under federal kickback charges tied to controversial gel H.P. Acthar, Mallinckrodt appeared to be out of the woods with a settlement in the...
New BIO chair hopes for greater policy focus on rare diseases
The newly elected chair of the the largest industry organization and lobbying group runs a company focused on drugs for rare diseases, and he...
Evolving gene could reduce type 2 diabetes risk
Changes in cooking and farming over the years have contributed to creating a common gene variant which could help people avoid developing...
After three-decade Merck career, Adam Schechter jumps for LabCorp CEO job
Thirty-one years is an eternity to spend at one pharma company, but Merck & Co. exec Adam Schechter has achieved that very feat. Now, he’s...
